Mads Nikolaj Behrndt-Eriksen
Chief Financial Officer and General Manager · 1 filing · Latest: Jan 29, 2026
Hemab Therapeutics Holdings, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Chief Financial Officer and General Manager · 1 filing · Latest: Jan 29, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|